Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma. - Wikidata - wikimedia - TriplyDB

Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.

Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.

http://www.wikidata.org/entity/Q33956039

about

Fifty years of melphalan use in hematopoietic stem cell transplantation Oliguria as an early indicator of mortality risk in patients with multiple myeloma and renal impairment.Bortezomib before and after autologous stem cell transplantation overcomes the negative prognostic impact of renal impairment in newly diagnosed multiple myeloma: a subgroup analysis from the HOVON-65/GMMG-HD4 trial.Changes in renal function after different tandem hematopoietic stem-cell transplantation approaches in patients with multiple myeloma.Autologous Hematopoietic Stem Cell Transplantation in Dialysis-Dependent Myeloma Patients.Variability of high-dose melphalan exposure on oral mucositis in patients undergoing prophylactic low-level laser therapy.Renal failure in multiple myeloma: a medical emergency.Management of hematological malignancies in patients affected by renal failure.Novel approaches for reducing free light chains in patients with myeloma kidney.Renal allografts in plasma cell myeloma hematopoietic cell graft recipients: on the verge of an explosion?Addressing the questions of tomorrow: melphalan and new combinations as conditioning regimens before autologous hematopoietic progenitor cell transplantation in multiple myeloma.Current treatments for renal failure due to multiple myeloma.Effect of melphalan 140 mg/m(2) vs 200 mg/m(2) on toxicities and outcomes in multiple myeloma patients undergoing single autologous stem cell transplantation-a single center experience.Recommended screening and preventive evaluation practices of adult candidates for hematopoietic stem cell transplantation.Melphalan 200 mg/m2 in patients with renal impairment is associated with increased short-term toxicity but improved response and longer treatment-free survival.Efficacy, toxicity and mortality of autologous SCT in multiple myeloma patients with dialysis-dependent renal failure.Evolving role of high dose stem cell therapy in multiple myeloma.Paraprotein-Related Kidney Disease: Evaluation and Treatment of Myeloma Cast Nephropathy.Stem cell mobilization in patients with dialysis-dependent multiple myeloma: Report of the Polish Myeloma Study Group.Evaluation of multiple myeloma patients presenting with renal failure in a university hospital in the year 2010.

P2860

Q26824498-E2C0F9D5-D439-426B-B897-ED830EAFBE97 Q33426615-E0BEBD2A-6E50-4C9D-9B12-F98077399FA7 Q33558161-3E69B993-A8A6-43D6-9AA5-8EC44E7C4D12 Q35333741-EB8C1976-F86D-4F5A-97BC-7AD361937E6C Q35893993-ADEB3936-4C60-4CC5-AB6B-F9992F89B32A Q36373735-00CB0E75-6990-4112-8D99-BC0EA35915F3 Q37845643-48A26B33-3688-41FC-A95A-40131C61324C Q37854710-94820CF7-6D6A-44FC-9FCC-303E84322E2B Q37986358-C14752CD-49E5-4B19-A847-8D6694C158F1 Q38021620-827916C4-059E-4AB9-9348-18227F00CA11 Q38095526-8D85CF9F-D43B-4968-B28C-D573FD2B2BBA Q38109235-79BD90E1-1FF2-4FAE-AFE5-D436FE7A9F6F Q38843140-39038D68-7AB5-40A3-9810-84FBFC197EB6 Q38937601-33695E10-A552-40DF-9D53-49FFEB87F80C Q39763521-32582C9D-BD17-4824-A159-3CDA8C1EB502 Q41714892-D2E49775-F129-40B1-A25D-8A7F9E3E7B17 Q42287525-133F9E3D-4B30-4FF1-8767-839C1ADC6DEE Q47162496-E6F0C871-FC8D-43FC-8E01-28081209F3BC Q47967442-CF186E01-F672-4A1C-B980-5F109613F360 Q50973983-486CCBC5-DAA8-449D-938D-C802EC9D9DF0

P2860

Autologous hematopoietic stem cell transplantation may reverse renal failure in patients with multiple myeloma.

http://www.wikidata.org/entity/Q33956039

description

2009 nî lūn-bûn

@nan

2009 թուականի Յուլիսին հրատարակուած գիտական յօդուած

@hyw

2009 թվականի հուլիսին հրատարակված գիտական հոդված

@hy

2009年の論文

@ja

2009年論文

@yue

2009年論文

@zh-hant

2009年論文

@zh-hk

2009年論文

@zh-mo

2009年論文

@zh-tw

2009年论文

@wuu

name

Autologous hematopoietic stem ...... atients with multiple myeloma.

@ast

Autologous hematopoietic stem ...... atients with multiple myeloma.

@en

type

label

Autologous hematopoietic stem ...... atients with multiple myeloma.

@ast

Autologous hematopoietic stem ...... atients with multiple myeloma.

@en

prefLabel

Autologous hematopoietic stem ...... atients with multiple myeloma.

@ast

Autologous hematopoietic stem ...... atients with multiple myeloma.

@en

P1433

Q33956039-0DCD24A2-0226-47E8-8D11-A9716A44B5EA

P1476

Q33956039-62465878-FA81-4A67-A39C-4C98F5C43BBC

P2093

Q33956039-00910D0A-4D06-4EEE-8CE5-CDBE26073F7D

Q33956039-209EA51D-3797-4FD3-A60F-7F30CE73093A

Q33956039-28DCC0C3-4E14-4C1F-9FAD-99F837B591FC

Q33956039-4045BA0E-95FC-4D70-A5D0-549B70849DA4

Q33956039-46EED413-56E2-44A8-A538-C52A86A598B1

Q33956039-4BBBD41B-9693-46E0-9836-131F3AAB664F

Q33956039-81AF377A-92E4-4E31-BEEB-ADA36A859A61

Q33956039-93AA4EFE-273F-4252-B83C-2E3A8C8628BC

Q33956039-996C6AC8-320D-41ED-B6E7-897E75A8FCEA

Q33956039-A3ABB488-FEFF-452F-8924-B8FFE62A2B07

P2860

Q33956039-1E7A3208-8DCF-4E62-921F-225259583557

Q33956039-4364B777-B2DD-4C2B-90F3-C57408416F76

Q33956039-52794289-CA57-47E7-AB31-0FB5A2565EEE

Q33956039-56860D81-290B-488F-AA6A-15C2278DC045

Q33956039-708F9C80-1E9A-4C1C-ABEE-E9902ECFA740

Q33956039-7A866F1F-FF67-4441-8FED-801A7FC4A6D2

Q33956039-7C7B9ED8-C96F-41ED-98F2-D0775FE842F2

Q33956039-88ECB141-8F77-4448-AD74-24245AF06384

Q33956039-B95CB1A2-1437-4CFB-AEC8-D681DF8BFA1E

Q33956039-C1757A7E-DA60-4935-A70E-FA22A8EE23BB

P304

Q33956039-9CBD7683-E470-4565-A175-1C63351EA0AD

P31

Q33956039-9EBE5ADA-D2A1-4F73-AB62-2F0CFE6125FB

P356

Q33956039-98BB14C9-56B5-4312-936F-EF3B31A89ED7

P433

Q33956039-99F27B04-8306-4E77-BE50-6945AB47B317

P478

Q33956039-8CDC972C-F378-4E12-A253-8EEE2C92D50B

P50

Q33956039-35748F47-E70F-4CF6-9E06-68C676CCA2CB

Q33956039-6A80EB58-7700-4DAD-A69A-9EABE86DD47D

P577

Q33956039-2909E37A-F4AD-49CD-9E04-33F42A82DA50

P5875

Q33956039-CF8ADE0A-8476-45C1-A419-1E90A68AC391

P698

Q33956039-C49F43F5-F890-4A1B-97B9-66FFD1FB2D7E

P932

Q33956039-83FBAE2A-F6A6-42E7-8212-ADB944A6BC85

P356

J.BBMT.2009.03.021

P1433

Biology of Blood and Marrow Transplantation

P1476

Autologous hematopoietic stem ...... patients with multiple myeloma

@en

P2093

Ali Imran Amjad

http://www.w3.org/2001/XMLSchema#string

Amin M Alousi

http://www.w3.org/2001/XMLSchema#string

Donna M Weber

http://www.w3.org/2001/XMLSchema#string

Floralyn Mendoza

http://www.w3.org/2001/XMLSchema#string

Gaurav C Parikh

http://www.w3.org/2001/XMLSchema#string

Michael Wang

http://www.w3.org/2001/XMLSchema#string

Muzaffar H Qazilbash

http://www.w3.org/2001/XMLSchema#string

Richard E Champlin

http://www.w3.org/2001/XMLSchema#string

Rima M Saliba

http://www.w3.org/2001/XMLSchema#string

Sergio A Giralt

http://www.w3.org/2001/XMLSchema#string

P2860

Encephalopathy complicating high-dose melphalan

Arsenic trioxide with ascorbic acid and high-dose melphalan: results of a phase II randomized trial

High-dose chemotherapy with hematopoietic stem-cell rescue for multiple myeloma.

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant.

Review of 1027 patients with newly diagnosed multiple myeloma.

Scleromyxedema: role of high-dose melphalan with autologous stem cell transplantation.

National Kidney Foundation practice guidelines for chronic kidney disease: evaluation, classification, and stratification

Renal function in newly diagnosed multiple myeloma--a demographic study of 1353 patients. The Nordic Myeloma Study Group.

Results of autologous stem cell transplant in multiple myeloma patients with renal failure.

Dialysis-dependent renal failure in patients with myeloma can be reversed by high-dose myeloablative therapy and autotransplant.

P304

812-816

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.BBMT.2009.03.021

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

15

http://www.w3.org/2001/XMLSchema#string

P50

P577

2009-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

26304020

http://www.w3.org/2001/XMLSchema#string

P698

19539212

http://www.w3.org/2001/XMLSchema#string

P932

4112358

http://www.w3.org/2001/XMLSchema#string